Clinical Context — Severe Preeclampsia and Seizure Prophylaxis
The client presents with a classic triad of severe preeclampsia: uncontrolled hypertension (
BP 170/110 mmHg), central nervous system irritability (severe headache, visual disturbances), and hepatic involvement (epigastric pain, elevated liver enzymes). This clinical picture signals a high risk for eclampsia, which necessitates the initiation of
magnesium sulfate for seizure prophylaxis. Before administering this high-alert medication, the nurse must prioritize safety checks to prevent catastrophic adverse effects, primarily respiratory depression and cardiac arrest due to magnesium toxicity.
Priority Intervention — Ensuring Antidote Availability
The priority nursing intervention is to
ensure that calcium gluconate is readily available at the bedside.
Magnesium sulfate acts as a central nervous system depressant and a calcium channel blocker. In the event of toxicity—which can occur rapidly, especially in clients with renal impairment—serum magnesium levels can rise, leading to loss of deep tendon reflexes, respiratory depression, and cardiac conduction abnormalities.
Calcium gluconate is the direct pharmacological antagonist; it works by displacing magnesium at the neuromuscular junction and cardiac cell membranes, reversing its toxic effects. Having it immediately accessible is a non-negotiable safety standard, as the time required to retrieve the antidote from a medication dispensing system could be fatal. This principle is a cornerstone of safe magnesium sulfate administration and is a critical knowledge point for healthcare providers managing pre-eclampsia, as highlighted in clinical practice assessments .
Analysis of Other Options
While the other interventions are important components of care, they are not the single most critical step immediately before starting the infusion.
- Option 1 (Assess deep tendon reflexes and clonus): This is a vital baseline assessment to monitor for magnesium toxicity, as the loss of patellar reflexes is often the first sign. However, it is a monitoring parameter, not a safety intervention that prevents death from an adverse reaction. The antidote must be present first.
- Option 3 (Insert a Foley catheter for hourly urine output): Magnesium is excreted renally, so monitoring urine output is essential to prevent toxicity. Insertion of a catheter is an important step but is secondary to the immediate availability of the life-saving antidote.
- Option 4 (Obtain a baseline serum magnesium level): A baseline level is helpful for monitoring, but in an emergency setting for seizure prophylaxis, the therapeutic window is guided more by clinical signs (reflexes, respiratory rate) than by a serum level, which may not result quickly enough. The physical presence of the antidote takes precedence over a laboratory draw.